Bharat Biotech

Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin

Centre Has Spent Rs 171 Crore So Far To Help Develop COVID Vaccines: RTI Reply

Covaxin Booster Has Neutralising Effect on Omicron, Delta: Bharat Biotech

42 Lakh Young Adults Received COVID Vaccines on First Day, Health Min Says

How Will Booster Doses, Shots for Minors Change India’s Vaccine Supply Calculus?

Prime Minister Modi’s December 25 Announcement Was an Affront to Expertise

COVID-19: Govt Panel Recommends EUA for Covovax, Corbevax and Molnupiravir